Mobia Medical
The Seagull Executive Verdict
Mobia Medical sells products and services in the Health Care market. The company went public in 2026 to raise cash from public stock markets.
Bankers told everyday buyers that Mobia Medical would grow fast and dominate its market.
The stock fell 27% after the IPO. Public investors lost money while early insiders took cash.
Capital Formation & Float Scarcity
Standard primary capital raise for general working capital.
Insider Lock-Up Expiration
Sector Peer & Cohort Telemetry
Mobia Medical is currently trading below the Health Care sector median of 21.64%. Across the entire 2026 calendar year cohort, only 78% of Health Care offerings have sustained a positive return above their initial offer price.